科伦药业: 2025年度第一期超短期融资券发行结果的公告

Core Points - Sichuan Kelun Pharmaceutical Co., Ltd. has received approval for the issuance of non-financial corporate debt financing tools, with a registered amount of RMB 4 billion for ultra-short-term financing bonds [1] - The company successfully issued its first ultra-short-term financing bond for 2025 on July 17, 2025, raising a total of RMB 800 million with a coupon rate of 1.6% [2] - The funds raised from this bond issuance will be used to repay interest-bearing debts and to supplement working capital [3] Summary by Sections Company Announcement - The board of directors approved the issuance of non-financial corporate debt financing tools on April 12, 2023, and it was subsequently approved by the shareholders' meeting on May 4, 2023 [1] - The company received a registration acceptance notice from the China Interbank Market Dealers Association on December 21, 2023, allowing the registration of ultra-short-term financing bonds [1] Bond Issuance Details - The first ultra-short-term financing bond for 2025 was issued on July 17, 2025, with a total issuance amount of RMB 800 million [2] - The bond has a maturity of 150 days, with an interest payment date set for December 14, 2025 [2] - The bond was rated AAA and was issued at a price of 100 yuan per 100 yuan face value [2] Fund Utilization - The proceeds from the bond issuance will be allocated for repaying interest-bearing liabilities and enhancing the company's liquidity [3]